TrialPharmaceutical research2017

Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients.

Tong Shen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.